A New Standard for Superior Drug Projections
Komodo uses a combination of multiple, distinct views of the U.S. healthcare system to provide the most accurate drug estimates on the market
![](https://www.komodohealth.com/wp-content/uploads/2024/12/Projections-900x600-v2.png)
An Advanced Projections Model
Access weekly, high-quality national and subnational projections for pharmacy- and medical-benefit drugs providing visibility at the individual account, HCP/HCO, and zip levels. View observed events and projected data side by side, with confidence intervals.
How It Works
Komodo Drug Projections’ advanced model is based on three pillars that ensure you obtain the most accurate projections for devising key metrics such as revenue forecast, market share, marketing ROI, and salesforce size.
![](https://www.komodohealth.com/wp-content/uploads/2024/12/Projections_How_01-1.png)
The Healthcare Map
Access the most complete view of the U.S. healthcare system, based on years of curating, acquiring, and transforming multiple datasets for unique insights. The data foundation in the Healthcare Map® offers the industry’s most comprehensive and accurate view into total dispenses for any market basket of drugs.
![](https://www.komodohealth.com/wp-content/uploads/2024/12/Projections_How_02-1.png)
Data Provider Diversity
Leverage the unique characteristics of payer- and provider-derived data and their intersection as the basis for your projections. These datasets offer views into subset populations through events covering the full patient journey and visibility into nearly every provider in the U.S. healthcare system.
![](https://www.komodohealth.com/wp-content/uploads/2024/12/Projections_How_03-1.png)
Multiple Statistical Methods
Calculate probability estimates of coverage for an individual drug, and incorporate learnings as new data is ingested. Monitor the consistency of a product’s payer and provider mix over time, and adjust accordingly to account for trend breaks and other disruptions.
See Komodo Drug Projections in Action
See the Unseen
Obtain a transparent and trustworthy view of the market landscape — no more black-box methodologies.
![](https://www.komodohealth.com/wp-content/uploads/2024/12/Projections_How_01-v2.png)
Track Market Share Across Multiple Drugs
Identify opportunities faster with key insights into your market to prioritize areas of focus, particularly in complex market baskets where therapies compete across Rx and Mx benefits. Identify the right competitive opportunities for maximum impact, and dive deeper into understanding peak market share.
![](https://www.komodohealth.com/wp-content/uploads/2024/12/Projections_How_03-v2.png)
Visualize Projected and Observed Insights — Together
Compare total observed vs. projected values in one simple dashboard for a holistic view of your market basket. Use confidence intervals to inform scenario models and sensitivity analyses. Utilize weekly projection factors to account for natural data lags, and enable analysts to fine-tune their own proprietary models.
![](https://www.komodohealth.com/wp-content/uploads/2024/12/Projections_How_02-v2.png)
Trend Multiple Drugs to Understand the Market
Track performance in real time with detailed competitive market share insights at both the drug and molecule level, including Rx and Mx classifications and gain visibility from the subnational to individual HCP and HCO levels. Track hard-to-project specialty and medical benefit drugs to report to stakeholders.
“[Komodo Drug Projections] presented a trend line that showed growth in an area that we weren’t expecting and we had not seen yet. And some of our other benchmarks and data partners didn’t have that timely data yet. So it really jumped off the page in terms of what [Projections] is able to do.”
![](https://www.komodohealth.com/wp-content/uploads/2024/12/Tim-Hughes-1-200x200.png)
Tim Hughes
Senior Director, Data Strategy and Innovation Global Oncology, Merck